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RESEARCH ARTICLE 
Summary. A Bacillus strain producing a bacteriocin-like substance was charac-
terized by biochemical profiling and 16S rDNA sequencing. Phylogenetic analysis
indicated that the strain has high sequence similarity with Bacillus amyloliquefa-
ciens. The antimicrobial substance was inhibitory to pathogenic and food-spoilage
bacteria, such as Listeria monocytogenes, Bacillus cereus, Serratia marcescens,
and Pasteurella haemolytica. It was stable over a wide temperature range, but lost
activity when the temperature reached 121°C/15 min. Maximum activity was
observed at acidic and neutral pH values, but not at alkaline pH. The antimicrobial
substance was sensitive to the proteolytic action of trypsin, papain, proteinase K,
and pronase E. Except for iturins, other antimicrobial peptides have not been des-
cribed for B. amyloliquefaciens. The identification of a bacteriocin-like inhibitory
substance active against L. monocytogenes addresses an important aspect of food
protection. [Int Microbiol 2006; 9(2):111-118]
Key words: Bacillus amyloliquefaciens · antimicrobial activity · bacteriocin ·
bioactive peptide
Introduction
Bacteriocins are proteins or peptides with bactericidal activ-
ity towards species that are often closely related to the pro-
ducer bacteria [29]. These substances, which are frequently
metabolites produced by various gram-positive and gram-
negative microorganisms [27], are heterogeneous com-
pounds that display variable molecular weights, biochemical
properties, inhibitory spectra, and mechanisms of action
[14,21,25]. Due to their potential use as natural preservatives,
bacteriocins produced by lactic acid bacteria have been the
subject of intensive investigation in recent years [7,23], and
many attempts are being made to incorporate bacteriocins
into processes and products [25].
Several bacteriocins or bacteriocin-like substances (BLS)
produced by the genus Bacillus have been reported [12,29].
The best-characterized are subtilin of B. subtilis [1,15],
megacin of B. megaterium [32], bacteriocins of B. cereus
[2,24], and bacteriocins of B. thuringiensis [9,26]. Although
several bacteriocin strains produce bacteriocins that are
active against a narrow spectrum of bacteria [26], others,
including important pathogens such as Listeria monocyto-
genes and Staphylococcus aureus, produce bacteriocins with
a broad spectrum of activity [24]. The ability to screen for a
bacteriocine-like substance (BLS)-producing Bacillus strains
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produced by Bacillus amylo-
liquefaciens isolated from
the Brazilian Atlantic forest 
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is of major interest in bacteriocin research since this genus
produces a diverse array of antimicrobial peptides with sev-
eral different basic chemical structures [10,28].
The Brazilian Atlantic forest is a unique ecosystem with
enormous biological diversity. The forest has been reduced to
less than 10% of its original size, but many efforts are now
being made to conserve the remaining biodiversity of this
region [19]. There are only a few studies on the microbial
diversity of this region [8,22] but no specific reports on
screening for biotechnologically relevant microorganisms.
The objective of the present study was to evaluate the potential
antimicrobial activity of bacteria isolated from native wood-
lands of southern Brazil. A BLS produced by a Bacillus sp.
was identified and its antimicrobial spectrum and properties
are described.
Materials and methods
Reagents and media. Trypticase soy broth (TSB) and nutrient broth
(NB) were from Difco (Detroit, MI, USA), brain-heart infusion (BHI), and
de Man-Rogosa-Shape (MRS) were from Oxoid (Basingstoke, UK). Papain,
trypsin, proteinase K, and pronase E were from Sigma (St. Louis, MO, USA).
All other media and reagents were from Merck (Darmstadt, Germany).
Bacterial cultures. Indicator strains listed in Table 1 are laboratory
stocks obtained from different sources. The strains were kept frozen in 20%
(v/v) glycerol at –20oC until needed and then under the culture conditions
indicated in Table 1.
Isolation of microorganisms. Soil samples were collected in the
native woodlands of Santa Catarina State, near Santo Amaro da Imperatiz
(27o24′S, 48o27′W), Brazil. This region corresponds to the southern part of
the Brazilian Atlantic Forest. The samples were obtained by removing the
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Table 1. Antimicrobial activity spectrum of the antimicrobial substance
Indicator organism Media Temp. (oC) Inhibition (mm)a
Gram-positive
Bacillus cereus ATCC 9634
Bacillus subtilis ATCC 9372
Corynebacterium fimi NCTC 7547
Lactobacillus acidophilus ATCC 4356
Lactococcus lactis R704
Listeria innocua (food isolate)
Listeria monocytogenes ATCC 7644
Micrococcus luteus (clinical isolate)
Enterococcus faecalis (clinical isolate)
Streptococcus sp. (α-haemolytic)
Staphylococcus 271
Staphylococcus aureus (food isolate)
Staphylococcus aureus ATCC 25923
















































Pasteurella haemolytica (clinical isolate)
Proteus vulgaris (clinical isolate)
Pseudomonas aeruginosa (clinical isolate)
Salmonella enteritidis (ATCC 13076)
Salmonella enteritidis (food isolate)
Salmonella gallinarium (clinical isolate)
Serratia marcescens (clinical isolate)
Erwinia carotovora (food isolate)
Escherichia coli ATCC 25922
































Candida kefir (food isolate)
Candida sp. (food isolate)
Kluyveromyces marxianus CBS 6556













aAliquots of 20 ml were applied to discs, corresponding to 8 activity units (AU) per disc. Values are the diame-
ter of the inhibition zone in mm around the disc and correspond to the means of three independent experiments.
bThe inhibitory zone was hazy.
Media: BHI, brain hearth infusion; MRS, de Man-Rogosa-Sharpe agar; BA, sheep blood agar; MYG, malt yeast glucose.
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leaf litter and collecting the top 10 cm of soil. Soil samples (100 g wet
weight) were mixed with sterile water (1:1 w/v), homogenized for 15 min at
60 cycles in a laboratory blender (Seward, London, UK), and allowed to
stand for 1 h at room temperature. One ml of this suspension was inoculated
into 100 ml of nutrient broth, after which microbial growth was monitored
by changes in the turbidity of the cultures. Aliquots of the cultures were
inoculated onto nutrient agar plates, incubated at 30oC, and single colonies
were isolated and screened for antimicrobial activity.
Antimicrobial activity assay. Antimicrobial activity was detected
by the agar-disk diffusion assay [13] and tested against all indicator strains.
An 20-ml aliquot of culture supernatant filtrate was applied to disks (6 mm)
placed on agar plates previously inoculated with a suspension of each indi-
cator strain. The plates were incubated at the optimal temperature of the test
organism. The bacteriocin titer was determined by the serial two-fold dilu-
tion method described in [20]. Activity was defined as the reciprocal of the
dilution after the last serial dilution giving a zone of inhibition and expressed
as activity units (AU) per milliliter.
Bacterial identification. Bacterial identification was based on 16S
rRNA gene sequencing analysis and biochemical analysis using the API 50
CHB test kit with automated interpretation (APILAB Plus, bioMérieux,
Marcy-l’Etoile, France). Additional morphological and physiological tests
were carried out as described elsewhere [18].’
Cloned 16S rDNA was sequenced using DYEnamic ET Dye Terminator
Cycle Kit for MegaBACE (a product from Amersham-Pharmacia Biotech,
Buckinghamshire, England) with the primers 16S-27 (5’-GAGTTTGATC-
CTGGCTCAG-3’) and 16S-1525 (5’-AGAAAGGAGGTGATCCAGCC-3’)
in an automatic sequencer (MegaBACE 1000, Amersham-Pharmacia Bio-
tech). Phylogenetic data were obtained by alignment of the 41 different 16S
rDNA sequences retrieved from the BLAST algorithm (National Center for
Biotechnology Information [http://www.ncbi.nlm.nih.gov]), using the soft-
ware CLUSTAL W version 1.8 [30] with the standard parameters. The align-
ments were visually corrected when necessary. Phylogenetic and molecular
evolutionary analyses were conducted using MEGA, version 2.1 [16]. An
unrooted phylogram was obtained by the neighbor-joining (NJ) method. An
interior branch test was done (heuristic option, 1000 replications) to check
the tree topology for robustness. Additionally, the Poisson correction was
applied to NJ for distance estimation, and the complete deletion option was
used in handling gaps or missing data obtained from the alignments.
BLS production under different conditions. The production of
antimicrobial activity was tested in six different media: TSB, nutrient broth,
BHI, Mueller-Hinton broth (MHB), lactose broth (3 g beef extract/l, 5 g pep-
tone/l, 5 g lactose/l), and peptone water (8 g NaCl/l, 1 g peptone/l) at differ-
ent incubation temperatures (30, 37, and 55oC) for up to 48 h. At the end of
each incubation period, antimicrobial activity was detected by the agar-disk
diffusion assay and tested against Bacillus cereus and Listeria monocyto-
genes as indicator strains.
Preparation of BLS. To produce BLS for characterization, the select-
ed strain was cultivated in 200 ml of BHI medium at 37oC in a rotary shak-
er at 125 cycles per min for 24 h. The cells were harvested by centrifugation
at 10,000 ×g for 15 min and culture supernatants were filtered through 0.22-
μm membranes. The culture filtrate was precipitated with ammonium sulfate
at 20% saturation and centrifuged at 10,000 ×g for 20 min at 4oC. The pellet
was resuspended in 10 mM sodium phosphate buffer (pH 6.0), and applied
to a Sephadex G-100 column eluted with this same buffer. Active fractions
were stored in sterile flasks at 4oC until used for antimicrobial assays.
Sensitivity of antimicrobial activity to proteolytic
enzymes and heat. The antimicrobial substance was treated at 37oC for
1 h with 2 and 10 mg of the following enzymes/ml (final concentration):
papain, trypsin, proteinase K, and pronase E. The samples were then boiled
for 2 min to inactivate the enzyme. To analyze thermal stability, samples of
bacteriocin were exposed to temperatures of 10, 40, 60, and 80oC for 30 min,
100oC for 5, 10, 15, 20, 30, 40, 50, and 60 min, and 121oC/105 kPa for 15
min. After treatment, the samples were tested for antimicrobial activity
against L. monocytogenes ATCC 7644.
Antimicrobial activity at different pH values. Samples of the
antimicrobial substance were diluted in the following buffers (0.25 M): (pH
3.0), citrate (pH 4.0–5.0), phosphate (pH 6.0–8.0), and Tris (pH 9.0–10.0).
After incubation for 2 h at 25oC, the antimicrobial activity against L. mono-
cytogenes was determined. Controls consisting of buffer alone were run in
parallel.
Activity on polyacrylamide gels. Antimicrobial activity was
detected on polyacrylamide gels as described previously [3]. Briefly, the
samples were applied to 14% polyacrylamide gels and electrophoresed at
20 mA per gel. The gels were then washed with sterile distilled water to
remove SDS and antimicrobial activity was tested against L. monocytogenes. 
Results
Isolation and identification of bacteriocin-pro-
ducing strain. Soil isolates were screened for antimicrobial
activity against Listeria monocytogenes, Bacillus cereus,
Escherichia coli, and Salmonella enteritidis. Four isolates that
showed antimicrobial activity against at least two indicator
strains were selected. Isolates I1 and I5 had antimicrobial activ-
ity against L. monocytogenes and B. cereus, while isolates I2
and I3 also inhibited E. coli. Since the inhibition zones of iso-
late I3 were the largest, it was selected for strain classification
and its antimicrobial activity was characterized. The I3 strain
was determined to be a gram-positive spore-forming bacterium
with a positive catalase reaction. Based on morphological and
biochemical examinations and the API 50 CHB results, strain
I3 was identified as a Bacillus species.
Isolate I3 was classified to the species level based on
sequence analysis of its 16S rDNA. CLUSTAL W and BLAST
were used to compare the 800-bp sequence with 41 other 16S
rRNA sequences from different Bacillus species present in
GenBank. Clustering analysis obtained by the NJ method
showed that the new isolate was taxonomically very close to
Bacillus amyloliquefaciens (Fig. 1), having 99% sequence
identity with B. amyloliquefaciens. This strain was assigned
the number LBM 5006 and deposited in our culture collection.
Bacteriocin production. Strain LBM 5006 was oxical-
ly incubated in several media at different temperatures in a
rotary shaker. Maximum antibacterial activity was evaluated
during stationary growth phase by cultivation in BHI at 37oC
(Fig. 2A). While similar levels of activity were observed at
30oC, growth was negligible and there was no antimicrobial
activity at 55oC. Antimicrobial activity was also produced dur-
ing cultivation in lactose broth, MHB, TSB, and nutrient broth
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(Fig. 2B). No activity against either B. cereus or L. monocyto-
genes was detected when the strain was cultivated in peptone.
Inhibitory spectrum. Supernatant filtrate (400 AU/ml)
was tested for the presence of antimicrobial activity against
several microorganisms, including gram-positive and gram-
negative bacteria and yeast. The results are shown in Table 1.
Inhibitory activity was observed towards several gram-posi-
tive bacteria, including important pathogenic microorgan-
isms such as B. cereus and L. monocytogenes. Among the
gram-negative bacteria tested, some clinically relevant bacte-










Fig. 1. Topological unrooted tree
obtained by neighbor-joining analysis of
the different Bacillus 16S rDNA
sequences. Bacillus amyloliquefaciens
strain LBM 5006 is indicated by a gray
box in the phylogram. Interior branch
analysis numbers (%) are shown in the
nodes of the phylogram. Branches with
interior branch analysis numbers < 50%
were collapsed.
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Serratia marcescens, were inhibited. When the supernatant
was concentrated (12,800 AU/ml), Staphylococcus aureus, E.
coli, and Enterococcus faecalis were also inhibited (Table 2).
None of the yeasts tested were inhibited, nor was the producer
strain inhibited by its own antimicrobial substance.
Effect of enzymes, pH, and heat on antimicro-
bial activity. The effect on the antimicrobial substance
(800 AU/ml) of the proteolytic enzymes papain, trypsin, pro-
teinase K, and pronase E was evaluated by measuring resid-
ual activity against L. monocytogenes ATCC 7644 in the
agar-disk diffusion assay. Antimicrobial activity was sensi-
tive to all proteases tested, but only at an enzyme concentra-
tion of 10 mg/ml.
The heat sensitivity of the antimicrobial substance was
determined by measuring its residual activity after incubation
for 30 min at different temperatures. It was stable at temper-
atures up to 80°C, but residual activity decreased at 100°C
(Table 3). All activity was lost after incubation at 121oC 
To evaluate the antimicrobial activity at different pHs, the
bacteriocin was incubated at 25oC at pH values between 3.0
and 10.0 for 2 h and activity was measured by the agar-disk
diffusion assay against L. monocytogenes ATCC 7644.
Activity was retained over a pH range of 3.0−8.0, but was
lost at alkaline pH values (pH 9.0 and 10.0) (Fig. 3).
Activity on gels. The fraction containing antimicrobial
activity was analyzed by SDS-PAGE, and a protein band









Fig. 2. (A) Growth (closed symbols) and antimicrobial activity (open circles) during cultivation of Bacillus
amyloliquefaciens strain LBM 5006 at 37oC in brain-heart infusion (BHI). (B) Antimicrobial activity at 48
h cultivation at 37oC in BHI, nutrient broth (NB), Mueller-Hinton broth (MHB), lactose broth (LacB), tryp-
ticase soy broth (TSB), and peptone.
Table 2. Antimicrobial activity spectrum of the freeze-dryed concentrated antimicrobial substance 
Indicator organism Medium Inhibition (mm)a
Staphylococcus aureus ATCC 25923
Staphylococcus aureus (food isolate)
Staphylococcus intermedius
Bacillus subtilis ATCC 9372
Enterococcus faecalis (clinical isolate)
Salmonella enteritidis (food isolate)
Escherichia coli ATCC 25922
Escherichia coli (clinical isolate)



















aAliquots of 20 ml were applied to discs, corresponding to 256 AU per disc. Values are the diameter of
the inhibition zone in mm around the disc and correspond to the mean of three independent experiments.
Media: BHI, brain hearth infusion; BA, sheep blood agar; MYG, malt yeast glucose. Growth at 37ºC.
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with an apparent molecular mass of about 5 kDa was identi-
fied (Fig. 4). A single band coinciding with the location of
antimicrobial activity was observed in the gel (Fig. 4).
Discussion
In the present investigation, bacterial strains isolated from
the soils of native woodlands of southern Brazil were sub-
jected to antimicrobial assay in order to obtain antimicrobial
substances. A newly isolated strain, identified as Bacillus sp.,
was found to be taxonomically very close to strains of B. amy-
loliquefaciens. This strain produces an antimicrobial substance
that inhibits B. cereus and L. monocytogenes, among other rel-
evant pathogenic bacteria. In addition, when concentrated by
lyophilization, the antimicrobial substance was able to inhibit
bacterial strains of S. aureus, E. coli, and Enterococcus fae-
calis, a very important property regarding food safety.
The antimicrobial substance was sensitive to all proteases
tested, suggesting that a peptide moiety is associated with its
activity. Although high protease concentrations were neces-
sary to inactivate the antimicrobial activity, some antimicro-
bials produced by Bacillus spp. are cyclic peptides containing
unusual amino acids, which are more resistant to proteases
[31]. The substance showed thermal resistance, since a total
loss of activity was observed only after incubation at 121oC.
This heat resistance, relative sensitivity to proteases, and low
molecular weight are common to group I bacteriocins [4,14].
The resistance to heat and proteases resembled that of a BLS
produced by Bacillus licheniformis P40 [5]. In addition, the
antimicrobial compound was inactive at alkaline pH, show-
ing maximum activity at acid pH values. Thus, the bacteri-
ocin may have features in common with nisin, which is 228
times more soluble at pH 2 than at pH 8 [17].
The antimicrobial substance was produced when the iso-
late was cultured in BHI but not in peptone, suggesting that
biosynthesis of the peptide requires a rich medium. By con-
LISBOA ET AL.
Table 3. Influence of temperature on the activity of antimicrobial substance



















aResidual activity compared with antimicrobial activity before the treatment.
Data are means of three independent experiments.
Fig. 3. Effect of pH on bacteriocin-like substance (BLS) activity. The antibac-
terial activity of BLS (800 AU ml-1) was assayed at various pH values.
Activity is expressed as the percentage of maximum activity determined









Fig. 4. Gel electrophoresis of the bacteriocin-like substance (BLS) of
Bacillus amyloliquefaciens strain LBM 5006. Samples of the antimicrobial
substance were submitted to SDS-PAGE and stained for proteins with
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trast, peptone appears to be a key nutrient for the production
of antifungal compounds by B. amyloliquefaciens RC-2 [33].
Also, maximum activity was observed at stationary growth
phase, which suggests that the antimicrobial peptide is pro-
duced as a secondary metabolite. However, it cannot be ruled
out that the compound is the specific product of gene tran-
scription and translation. B. amyloliquefaciens is closely relat-
ed to Bacillus subtilis. The production of antimicrobial pep-
tides by strains of B. subtilis is thought to be under complex
genetic regulation. It has been observed that modifications of
the culture conditions, including nitrogen source and pH, may
induce the production of different peptide antibiotics [6].
Although many of the properties of B. amyloliquefaciens are
similar to those of B. subtilis, its ability to produce an antag-
onist of microbial growth has not been frequently reported.
Bacillus spp. appear to be a relatively abundant source of
antimicrobials, since many species of this genus synthesize
antimicrobial peptides [10,28]. B. amyloliquefaciens is known
to produce iturins, a family of cyclic lipopeptide antibiotics,
[11]. These molecules have seven α-amino acids and one
β-amino fatty acid, and iturin A is produced as a mixture of up
to eight isomers [34]. B. amyloliquefaciens strains producing
iturin A2 have been used as biocontrol agents to suppress fun-
gal plant pathogens [33,34]. The BLS isolated in this work
may be a macrolactone rather than an iturinic peptide, since
the latter are well-established antifungal agents with distinct
properties [33,34]. Instead, identification and characterization
of the bacteriocin-like substance produced by B. amylolique-
faciens strain LBM 5006 may represent a novel antimicrobial
substance with potential applications in food safety, with
important implications for the biological control of pathogen-
ic and spoilage microorganisms, and thus for food protection.
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Caracterización de una substancia 
del tipo bacteriocina producida por 
Bacillus amyloliquefaciens aislado 
del bosque atlántico brasileño 
Resumen. Se ha caracterizado una cepa de Bacillus productora de una subs-
tancia del tipo bacteriocina mediante perfiles bioquímicos y secuenciación
del rDNA 16S. El análisis filogenético indicó que la cepa presentaba una gran
similitud de secuencia con Bacillus amyloliquefaciens. La sustancia antimi-
crobiana era inhibitoria para algunas bacterias patógenas y causantes del de-
terioro de los alimentos como Listeria monocytogenes, Bacillus cereus, Se-
rratia marcescens y Pasteurella haemolytica. La sustancia era estable en una
amplia gama de temperaturas, pero perdía la actividad cuando la temperatura
alcanzaba 121°C/15 min. La actividad máxima fue observada a valores de pH
ácidos y neutros, pero no a pH alcalinos. La sustancia antimicrobiana era
sensible a la acción proteolítica de la tripsina, la papaína, la proteinasa K y la
pronasa E. Excepto las iturinaos, no se han descrito otros péptidos antimi-
crobianos de B. amyloliquefaciens. La identificación de una sustancia tipo
bacteriocina activa contra L. monocytogenes cubre un aspecto importante en
la protección de los alimentos. [Int. Microbiol 2006; 9(2):111-118]
Palabras clave: Bacillus amyloliquefaciens · actividad antimicrobiana ·
bacteriocina · péptido bioactivo
Caracterização de uma substância 
do tipo bacteriocina produzida por 
Bacillus amyloliquefaciens isolado 
da Mata Atlântica brasileira 
Resumo. Uma linhagem de Bacillus produtora de uma substância tipo-
bacteriocina foi caracterizada por  perfil bioquímico e sequenciamento do
rDNA 16S. A análise filogenética indicou que a linhagem tem una grande
similitude de sequência com Bacillus amyloliquefaciens. A substância anti-
microbiana inibiu bactérias patogênicas e deteriorantes como Listeria mo-
nocytogenes, Bacillus cereus, Serratia marcescens e Pasteurella haemolyti-
ca. A substância antimicrobiana foi estável num amplo intervalo de tempera-
tura, mas perdeu atividade quando a temperatura foi de 121°C/15 min. A ati-
vidade máxima foi observada em valores de pH ácidos e neutros, mas não em
pH alcalino. A substância antimicrobiana foi sensível frente à ação proteolí-
tica da tripsina, da papaína, da proteinase K e da pronase E. Com excepção
das iturinas, outros peptídeos antimicrobianos não estão descritos em B. amy-
loliquefaciens. A identificação de uma substância inibitória tipo bacteriocina
com atividade contra L. monocytogenes atende a um aspecto importante da
protecção dos alimentos. [Int Microbiol 2006; 9(2):111-118]
Palavras chave: Bacillus amyloliquefaciens · atividade antimicrobiana ·
bacteriocina · peptídeo bioativo
